Monitoring peripheral immune blood cells as predictors of efficacy and toxicity in patients with solid tumors treated with checkpoint inhibitors (PEPITA)

Monitoring peripheral immune blood cells as predictors of efficacy and toxicity in patients with solid tumors treated with checkpoint inhibitors (PEPITA)

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Capofila

Unità Operativa

UOC Oncologia 2

Ente finanziatore

IOV - IRCCS

Principal Investigator

Prof.ssa Valentina Guarneri

Anno di finanziamento

2018
Scroll to Top